Chloroprocaine Hydrochloride

盐酸氯普鲁卡因

Report date: 2023/01/18 11:36:00

Base Information

Drug NameChloroprocaine Hydrochloride
Drug Alias Name氯普鲁卡因盐酸盐Chloroprocainum盐酸纳塞卡因NesacaineNesacaine-Mpf +[8] 
ClassificationSmall molecules
Mechanisms of ActionSodium channels blockers
TargetsSodium channels
Therapy Area/IndicationsParturitionPainHernia, Inguinal +[6] 
Global Approved IndicationsAnesthesia
Approved Indications in ChinaAnesthesia
Original Approved Country/TerritoryUnited States
Original Approved Date1955/03/11
Country/TerritoryUnited StatesItalySwitzerland +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesFresenius Kabi Ag
China Registration ClassN/A

Develop Information

Active CompaniesHarrow Health IncSintetica SaFresenius Kabi Manufacturing Sa +[4] 
Inactive CompaniesJohns Hopkins UniversityUniversity Of Alabama At Birmingham
Active IndicationsHernia, InguinalFlatfootAnesthesia
Inactive IndicationsParturitionPainPregnancy Complications

Other Information

ATC CodeN01BA04
Related LinksWikipediaDrugBankKEGG